NewslettersCancer Stem Cell NewsIntestinal Cell News Dihydroartemisinin Inhibited Stem Cell-Like Properties and Enhanced Oxaliplatin Sensitivity of Colorectal Cancer via AKT/mTOR Signaling By Noshin Noorjahan - May 3, 2023 0 Researchers found that dihydroartemisinin (DHA) inhibited cell viability in HCT116 and SW620 cells. Moreover, DHA decreased cell clonogenicity, and improved oxaliplatin sensitivity. [Drug Development Research] Abstract